Breaking News
1 day ago
Vaibhavi M.

Celularity names Rick Gonzalez CCO to drive global commercialization of cenplacel-L and Lifebank across permissive international markets.
Vaibhavi M.

Novartis files Cosentyx for PMR in US, EU, and Japan after Phase III REPLENISH data showed double the sustained remission rate vs placebo.
Vaibhavi M.

FDA publishes RWE landscape analysis covering approvals, labeling changes, and no-action determinations across CDER, CBER, and CDRH since 2011.
Vaibhavi M.

Omnix Medical doses first Phase II patients with OMN6, a first-in-class antimicrobial targeting drug-resistant Acinetobacter baumannii.
Vaibhavi M.
